GDP is a quality assurance system for warehouse companies and wholesale organizations in the area of circulation of medicines. According to the internationally accepted GDP regulations, the distributors of pharmaceutical products must bring their operations in line with these standards. The implementation of GDP rules ensures the availability of consistent quality management systems across the supply chain ranging from the supplies of raw materials to manufacturing facilities and to shipment of finished products to end users.
“Maintaining high standards set by the state authorities of Kazakhstan for suppliers of medicines will help R-Pharm to ensure the proper quality of its products. It is important to mention that R-Pharm Kazakhtan was the first to receive GDP certificate within the group of companies in CIS. This document will help to improve the accessibility of modern high-tech therapies for patients in Kazakhstan,” said Viktor Ryazanov, the Director of R-Pharm Kazakhstan LLP.